Effectiveness of treatment for chronic tension headache by the general practitioner or manual therapist: pilot study for a randomized clinical trial

Effectiveness of treatment for chronic tension headache by the general practitioner or manual therapist: pilot study for a randomized clinical trial - Manual therapy for tension headache

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30066

Enrollment

Registered

2006-07-04

Start date

2006-05-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chonic tension headache tension headache

Interventions

After selection and baseline assessment a total of 20 participants with CSSH will be randomly allocated to manual therapy (n=10) or usual GP care (n=10). The treatment protocol for manual therapy co

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronic tension headache according to the classification of the International Headache Society (IHS), age 18-65 year, able to complete written questionnaires in Dutch; informed consent.

Exclusion criteria

Exclusion criteria: Reumatic diseases, fever, pregnancy, possibility of malignancy, manual therapy for chronic tension headache in preceding 2 months.

Design outcomes

Primary

Measure	Time frame
The baseline assessment includes a questionnaire regarding general health, headache, and medication use, limitations in daily functioning, and an assessment of the mobility of the cervical spine (using a Cervical Range Of Movement goniometer). Furthermore, an algometer will be used to measure tender points of the m trapezius descendens. Outcomes are assessed after treatment (8 weeks) en after 26 weeks. Primary outcome measures are 1) frequency of headache (headache diary) and 2) medication use (diary).	—

Measure

Time frame

The baseline assessment includes a questionnaire regarding general health, headache, and medication use, limitations in daily functioning, and an assessment of the mobility of the cervical spine (using a Cervical Range Of Movement goniometer). Furthermore, an algometer will be used to measure tender points of the m trapezius descendens. Outcomes are assessed after treatment (8 weeks) en after 26 weeks. Primary outcome measures are 1) frequency of headache (headache diary) and 2) medication use (diary).

—

Secondary

Measure	Time frame
Secundary outcome measures are: perceived recovery, limitations in daily activities, mobiilty of the cervical spine, and tender points of the m. trapezius descendens.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)